NEW YORK (GenomeWeb News) – Ambry Genetics has become a certified service provider for the Roche NimbleGen SeqCap EZ Exome workflow, the firms announced today.
Aliso Viejo, Calif.-based Ambry will provide target enrichment services using SeqCap EZ Human Exome combined with next-generation sequencing services.
The SeqCap EZ Exome technology uses a single tube of stable DNA oligos to capture all exons in solution in a simple, scalable workflow, and contains 2.1 million empirically optimized DNA probes, according to Roche NimbleGen.
Under the partnership, Ambry will process customers' genomic DNA samples for enrichment using SeqCap to capture all human coding exons, and sequence the enriched samples using short-read, paired-end sequencing. According to the firms, Ambry is Roche NimbleGen's first service provider in the US offering the SeqCap EZ Human Exome product.